Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Wilmer Roberts

Urology Lake Jackson, TX Medical Doctor

NPI 1346391653 CMS profile 1028083

210 Lake Rd Ste 200, Lake Jackson, TX 77566

Open in the dashboard

General payments

$3,853

66 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Wilmer Roberts of Lake Jackson, TX is reported in the CMS Open Payments database as having received $3,853 across 66 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $144 5
2024 General $454 12
2023 General $1,475 14
2022 General $1,310 12
2021 General $271 12
2020 General $29 1
2019 General $169 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Wilmer Roberts
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Wilmer Roberts were reported at $144. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Wilmer Roberts Urology median Middle half National median
2019 $169 $480 $147–$1,201 $163
2020 $29 $246 $87–$645 $114
2021 $271 $358 $111–$1,000 $132
2022 $1,310 $476 $143–$1,263 $149
2023 $1,475 $560 $168–$1,461 $160
2024 $454 $563 $170–$1,464 $164
2025 $144 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Teleflex LLC $2,562 17 payments
  2. Astellas Pharma US Inc $249 11 payments
  3. Medtronic, Inc. $198 4 payments
  4. Axonics Modulation Technologies, Inc. $184 5 payments
  5. Boston Scientific Corporation $109 4 payments
  6. 180 Medical, Inc. $78 3 payments
  7. Urogen Pharma, Inc. $58 2 payments
  8. Myovant Sciences Inc. $57 3 payments
  9. Laborie Medical Technologies Corp. $52 2 payments
  10. Antares Pharma, Inc. $44 1 payment
  11. Other $263 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,118 61 payments
  2. Travel and Lodging $1,736 5 payments
Products named General payments · program years 2019–2025
  1. UROLIFT Interventional Urology $2,314 14 payments
  2. Axonics $204 6 payments
  3. XTANDI $179 7 payments
  4. INTERSTIM $170 3 payments
  5. MYRBETRIQ $110 6 payments
  6. ORGOVYX $91 5 payments
  7. rezum Generator $66 2 payments
  8. JELMYTO $58 2 payments
  9. UROLIFT Interventional Urology $45 1 payment
  10. NOCDURNA $44 1 payment
  11. Other $333 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 29 drugs

Part D claims

2,951

Median for Urology: 1,053

Drug cost

$165,373

Median for Urology: $101,464

Branded share of claims

26.1%

Median for Urology: 27.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 144 $97,814
Solifenacin Succinate Generic 344 $15,775
Tamsulosin Hcl Generic 1,105 $14,980
Mirabegron Er Mirabegron Brand 15 $11,732
Finasteride Generic 333 $4,983
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst Brand 102 $4,854
Alfuzosin Hcl Er Alfuzosin Hcl Brand 169 $3,210
Tolterodine Tartrate Er Tolterodine Tartrate Brand 27 $1,989
Testosterone Cypionate Generic 30 $1,338
Potassium Citrate Er Potassium Citrate Brand 27 $1,324

The 10 drugs with the highest cost, of 29 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 77 billing codes

Paid by Medicare

$125,242

Of which drugs: $3,238

Medicare patients

286

Average age 74

Services billed

2,401

61 women, 225 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 42%
Diabetes 41%
Arthritis 36%
Chronic kidney disease 33%
Atrial fibrillation 26%
Heart failure 23%
Cancer 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ORGOVYX
  • Sumitomo Pharma America, Inc. $34
$34 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

66 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record